Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum

Peptides

Volumn 22, Issue 7, 2001, Pages 1129-1138

  Roumi, Marie ^a   Kwong, Elizabeth ^b   Deghenghi, Romano ^c   Locatelli, Vittorio ^d   Marleau, Sylvie ^a   Du Souich, Patrick ^a   Béliveau, Richard ^e   Ong, Huy ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^c Ardana   (France)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

EP 51389; Growth hormone releasing peptides; Hexarelin; In vitro diffusion cell chambers; Intestinal permeability; P glycoprotein; Rat intestinal segments

Indexed keywords

CHLORPROMAZINE; EDETIC ACID; EP 51389; EP 91002; GLYCOPROTEIN P; GROWTH HORMONE; HEXARELIN; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DIFFUSION CHAMBER; DOSE RESPONSE; DOSE TIME EFFECT RELATION; EFFUSION; GROWTH HORMONE RELEASE; HORMONE TRANSPORT; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TRANSCYTOSIS;

ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CHLORPROMAZINE; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; EDETIC ACID; GROWTH HORMONE; JEJUNUM; MALE; MODELS, THEORETICAL; OLIGOPEPTIDES; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINE 123; TIME FACTORS;

EID: 0034977048     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00435-1     Document Type: Article

References (41)

1. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin
2. The pharmacological role of P-glycoprotein in the intestinal epithelium
3. Fundamental releationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells
4. In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption
5. Growth hormone-releasing peptides and their analogs
6. Hexarelin, a potent GHRP analogue: Interactions with GHRH, and clonidine in young, and aged dogs
7. Disposition of RS-26306, a potent lutenizing hormone-releasing hormone antagonist, in monkeys and rats after single intravenous and s.c. administration
8. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
9. GH releasing properties of hexarelin (EP 23905)
10. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant, and adult rats
11. The development of "impervious peptides" as growth hormone secretagogues
12. Structural requirements of growth hormone secretagogues
13. A potent, orally bioavailable benzazepinone growth hormone secretagogue
14. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine
15. Orally active growth hormone secretagogues: State of the art and clinical perspectives
16. Growth hormone releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, s.c., intranasal, and oral administration in man
17. Biochemistry of multidrug resistance mediated by the multidrug transporter
18. In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell
19. Pharmacological characterisation of a new oral GH secretagogue, NN703
20. Untoward events in patients treated with growth hormone in the USA
21. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
22. MDCK (Madin-Darby canine kidney)cells: A tool for membrane permeability screening
23. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney, and other tissues
24. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment
25. Transport of celiprolol across human intestinal epithelial (caco-2) cells: Mediation of secretion by multiple transporters including P-glycoprotein
26. The intestinal oligopeptide transporter
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in caco-2 monolayers
29. Disposition of Sandostatin, a new synthetic somatostatin analogue, in rats
30. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption
31. Multidrug-resistance phenotype in chinese hamster ovary cells
32. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat
33. Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver
34. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats
35. Possible involvement of multiple p-glycoprotein-mediated efflux systems in the transport of verapamil and other cations across rat intestine
36. The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum
37. Peptide transport by the multidrug resistance pump
38. Peptidomimetic regulation of growth hormone secretion
39. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier
40. Membrane transport of drugs in different regions of the intestinal tract of the rat
41. Effects of different absorption enhancers on the permeation of ebirate, an ACTH analogue, across intestinal membranes